Suppression of human tumor cell proliferation through mitochondrial targeting
Inform patients using these concomitant medications of the risk of hypoglycemia and educate them on the signs and symptoms of hypoglycemia
One recent study suggests that semaglutide and other similar drugs may be studied for future use as taste-altering medications
Van der Jeugd A, Parra-Damas A, Baeta-Corral R, Soto-Fagus CM, Ahmed T, LaFerla FM, et al
Paquette MA, Brudney EG, Putterman DB, Meshul CK, Johnson SW, Berger SP
Chronic neuroinflammation has been reported to contribute to serotonergic, dopaminergic, and noradrenergic dysfunction in the brain (Song and Wang, 2011) and to lead to chronic immune dysregulation ( Figure 2 Previous studies found that pro-inflammatory cytokines, including tumor necrosis factor- (TNF-) and interleukin (IL)-6, IL-1, and C-reactive protein (CRP), are markedly increased in the blood and CSF of patients with depression (Hestad et al., 2016